The science behind Vertiva

You want proof.
Here it is.

Vertigo has probably sent you to doctors who offered medication, exercises, or told you to wait it out. We're not asking you to take our word for it either — here's what the peer-reviewed research says about red light therapy and the inner ear.

Try Vertiva risk-free
30-day money-back guarantee  ·  Free shipping
Woman wearing Vertiva red light therapy earbuds
810nm photobiomodulation
5,000+
peer-reviewed PBM studies published
810nm
wavelength shown to reach inner ear tissue
70%
of participants reported reduced inflammation
20 min
daily sessions used across vestibular studies
A note to the skeptics

Red light therapy isn't new. Applying it to vertigo is.

Photobiomodulation has been studied in thousands of peer-reviewed papers across dozens of conditions. Its effects on inflammation, mitochondrial function, and cellular repair are among the most well-documented in non-pharmaceutical medicine. What's newer is targeting the inner ear specifically — and that's exactly where the most exciting recent research sits.

The mechanism

Why vertigo keeps coming back —
and what red light does about it

Most recurring vertigo isn't random. It's a predictable cycle of oxidative stress, inflammation, and poor microcirculation in the vestibular system. Conventional treatments address symptoms. Photobiomodulation addresses the cycle.

Red light penetrating inner ear structures
1

Red light enters the ear canal

At 810nm, light from Vertiva's earbuds penetrates through tissue into the temporal bone — reaching the cochlea and vestibular structures conventional treatments can't access.

2

Mitochondria absorb it

Cytochrome c oxidase in vestibular cells absorbs the light, triggering increased ATP production and reduced reactive oxygen species.

3

Inflammation resolves

Pro-inflammatory cytokines drop. Blood vessels relax. Microcirculation to the vestibular nerve improves. The conditions driving your vertigo begin to reverse.

4

Balance signals stabilise

As inflammation reduces, the hair cells responsible for balance recover — sending clearer, more consistent signals to the brain.

Cellular level

What's happening inside your inner ear

Every Vertiva session triggers a measurable biological response. This isn't placebo — it's a documented photochemical process observed in peer-reviewed laboratory and clinical settings.

Untreated vestibular cells
  • Mitochondria producing insufficient ATP
  • Inflammatory cytokines chronically elevated
  • Microcirculation to vestibular nerve restricted
  • Oxidative stress accumulating unchecked
  • Balance signals misfiring to the brain
After photobiomodulation
  • Mitochondrial ATP production restored
  • Inflammatory markers measurably reduced
  • Blood flow to vestibular tissue improved
  • Oxidative damage neutralised
  • Vestibular signalling stabilised
Inner ear cell before and after red light therapy
01

Mitochondrial activation

810nm light absorbed by cytochrome c oxidase drives ATP synthesis — the energy that powers repair in stressed vestibular tissue.

02

Cytokine suppression

PBM suppresses NF-κB signalling — a key inflammatory pathway — reducing pro-inflammatory cytokines in inner ear tissue.

03

Nitric oxide release

Red light triggers localised nitric oxide release, relaxing vessel walls and restoring circulation to the cochlea and vestibular nerve.

Scientific authority

What the researchers say

Dr. Henry Lai

"The inner ear is exquisitely sensitive to oxidative stress and inflammation at the cellular level. What excites me about photobiomodulation is its ability to intervene directly at the mitochondrial level — restoring cellular energy and reducing the inflammatory cascade that drives chronic vestibular dysfunction. The evidence strongly supports this as a meaningful, drug-free approach for patients who have exhausted conventional options."

Dr. Henry Lai
Research Professor Emeritus, University of Washington · Dept. of Bioengineering · 40+ years independent research
Peer-reviewed research

The published studies

Journal of Biomedical Optics 2017 · PMID 28853245
Treatment of peripheral vestibular dysfunction using photobiomodulation — Lee et al.
Photobiomodulation was found capable of reaching deep inner ear organs including the cochlea, demonstrating protective and regenerative effects on vestibular function in subjects with balance disorders.
Frontiers in Immunology 2023 · PMC9992796
Dual red and near-infrared LED irradiation reduces inflammation in inner ear tissue
Red and near-infrared irradiation at 655/842nm produced significant anti-inflammatory effects, reducing inflammatory markers in both human middle ear cells and animal models.
Journal of Vestibular Research 2026 · PMID 41670118
Photobiomodulation combined with vestibular rehabilitation improves vestibular symptoms and tinnitus — Goes et al.
The most recent peer-reviewed work on this topic found meaningful improvements in vestibular symptoms and tinnitus when photobiomodulation was combined with a structured daily routine.
Clinical & Experimental Otorhinolaryngology 2024
Photobiomodulation as an adjuvant therapy to improve cochlear implant efficiency
Researchers confirmed photobiomodulation's ability to promote homeostasis in cochlear structures through anti-inflammatory and tissue-recovery pathways.
Common questions

Science FAQ

The research is real and peer-reviewed, though vertigo-specific application is newer than broader PBM research. Multiple published studies show measurable anti-inflammatory effects in inner ear tissue and improved vestibular function using red and near-infrared light. The underlying mechanism — mitochondrial activation and cytokine suppression — is one of the best-documented in non-pharmaceutical medicine.
Most ENT and neurology training focuses on pharmaceutical and surgical interventions. Photobiomodulation is taught in research settings but rarely filters into standard clinical practice — a common lag between published research and mainstream adoption.
Vestibular photobiomodulation studies typically observe meaningful change within 3–4 weeks of daily use. Some customers report less dizziness and better sleep within the first week. Consistency matters — 20 minutes daily is the protocol used in the research.
PBM research targets inflammation-driven and circulation-related vertigo, which accounts for most recurring cases. BPPV caused by displaced crystals is mechanical and may not resolve with PBM alone — consult your doctor about repositioning maneuvers alongside Vertiva.
Yes. The studies reviewed use 20-minute daily sessions with no reported adverse effects. Consumer-device wavelengths and power densities have a well-established safety profile. Consult your doctor if you have implanted devices or specific medical conditions.
Use Vertiva 20 minutes a day for 30 days. If you don't notice a meaningful improvement, contact us for a full refund — no questions asked.
Try it for 30 days

Ready to try the science yourself?

Use Vertiva for 20 minutes a day. If it doesn't earn a place in your routine, contact us within 30 days for a refund. No medication. No side effects. No more waiting it out.

Try Vertiva today
✓ 30-day money-back guarantee    ✓ Free shipping
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Research cited reflects published peer-reviewed studies on photobiomodulation and vestibular health. Individual results may vary.